DDX17 and hepatocellular carcinoma: Results showed that DDX17 knockdown also inhibited HCC cell proliferation (Supplementary Fig. 1b–d), and results showed that loss of DDX17 remained weak ability to inhibit HCC cell proliferation although the majority of its ability disappeared in Klf4-depletion condition.